American Capital Advisory, LLC Royalty Pharma PLC Transaction History
American Capital Advisory, LLC
- $115 Billion
- Q1 2024
A detailed history of American Capital Advisory, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, American Capital Advisory, LLC holds 1,000 shares of RPRX stock, worth $25,730. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,000
Previous 900
11.11%
Holding current value
$25,730
Previous $25.3 Million
42.52%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
393Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.14 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$970 Million0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$546 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$429 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$296 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...